Jasper Therapeutics, Inc. - 8-K Filing
Jasper Therapeutics acquires Kira Pharmaceuticals in all-stock transaction, raises $132M through private placement to fund operations until late 2028. (Items: 7.01 of this Current Report on Form 8-K, including the information in the press release attached as Exhibit 99)
Tickers: $JSPR